Long-acting lenacapavir is a breakthrough for preventing HIV infection, but HIV vaccine research must continue
Related Experiment Video
Updated: Jun 12, 2025

07:18
High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
5.8K
Caijun Sun1, Linghua Li2, Pingchao Li3
1School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, China.
Frontiers of Medicine
|June 11, 2025
Abstract
No abstract available in PubMed .

